The COVID-19 pandemic wrought effects on global markets throughout 2020, and into 2021, with companies struggling to perform business as they usually would.
Despite this, medtech companies fared better than many other major sectors. According to Simon-Kucher & Partners’ 2021 Global Pricing Study,...